SPPI is getting ready to run. End of day volume bursts and a nice uptrend formation with an inminent neckline break
We just need some more volume.
Low risk entry right at the support area.
The upside is overwhelming.
Just a thought
Wanting entry to be close to $3.92 as possible. Looking at the arrows, gaps needs to be filled and looks like bears still have more pressure, and S &R still has room to go lower. Will update when I enter
Right now if you look at the tumbling pattern for SPPI, from the outside it looks terrible. It looks absolutely awful. However, for an entry price after this horrid plunge, it is quite considerable. SPPI looks like it has been oversold, and that the breakout potential looks to be there now. Right now, I think the entry is decent with mid to high risk given...
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.